# Zinc and Green Tea Extract for Community Respiratory Viral Infections

> **NCT04898023** · PHASE2 · TERMINATED · sponsor: **University of Missouri-Columbia** · enrollment: 17 (actual)

## Conditions studied

- Respiratory Viral Infection

## Interventions

- **DRUG:** zinc-green tea extract-ascorbic acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04898023
- **Lead sponsor:** University of Missouri-Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-09-21
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-12-20
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Loss of funding
- **Last updated:** 2025-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04898023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04898023, "Zinc and Green Tea Extract for Community Respiratory Viral Infections". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04898023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*